Showing results (21-30 of 83) with videos related to

Sort By:
Pageof 9
Journal of Clinical Medicine|December 17, 2024
Treatment Sequencing and Independent Outcomes of First- and Second-Line Chemotherapy in a Retrospective Series of Patients with Biliary Tract CancerGiorgio Frega, Andrea Palloni, Chiara Deiana, et al.
Current Oncology (Toronto, Ont.)|January 20, 2023
Immune-Based Combinations versus Sorafenib as First-Line Treatment for Advanced Hepatocellular Carcinoma: A Meta-AnalysisAlessandro Rizzo, Angela Dalia Ricci, Annarita Fanizzi, et al.
Frontiers in Oncology|May 11, 2023
Are FGFR and IDH1-2 alterations a positive prognostic factor in intrahepatic cholangiocarcinoma? An unresolved issueGiovanni Brandi, Chiara Deiana, Linda Galvani, et al.
Expert Opinion on Investigational Drugs|November 21, 2020
Experimental HER2- targeted therapies for biliary tract cancerAlessandro Rizzo, Angela Dalia Ricci, Chiara Bonucci, et al.
Therapeutic Advances in Medical Oncology|July 21, 2020
Dose reduction and discontinuation of standard-dose regorafenib associated with adverse drug events in cancer patients: a systematic review and meta-analysisAlessandro Rizzo, Margherita Nannini, Marco Novelli, et al.
Future Oncology (London, England)|January 20, 2022
Impact of clinicopathological features on immune-based combinations for advanced urothelial carcinoma: a meta-analysisAlessandro Rizzo, Veronica Mollica, Matteo Santoni, et al.
Frontiers in Oncology|January 3, 2022
Predictive Biomarkers for Checkpoint Inhibitor-Based Immunotherapy in Hepatocellular Carcinoma: Where Do We Stand?Alessandro Rizzo, Angela Dalia Ricci, Alessandro Di Federico, et al.
Future Oncology (London, England)|August 25, 2021
Systemic and liver-directed therapies in metastatic uveal melanoma: state-of-the-art and novel perspectivesFrancesca Comito, Paola Valeria Marchese, Angela Dalia Ricci, et al.
Expert Opinion on Investigational Drugs|December 14, 2020
Nivolumab: an investigational agent for the treatment of biliary tract cancerAlessandro Di Federico, Alessandro Rizzo, Angela Dalia Ricci, et al.
Current Oncology (Toronto, Ont.)|February 24, 2022
Systemic Treatment for Metastatic Biliary Tract Cancer: State of the Art and a Glimpse to the FutureAlessandro Rizzo, Angela Dalia Ricci, Antonio Cusmai, et al.
Pageof 9